Fourteen years after the Congressional deadline, the long-anticipated revision to the 340B Administrative Dispute Resolution (ADR) process officially took effect [...] …
Category: Pharma Industry
Drug manufacturer Novartis uses contradictory, “whiplash-inducing” arguments in its lawsuit challenging Mississippi’s 340B contract pharmacy law, hospital groups told a [...] …
The Delaware House late last week overwhelmingly passed a bill to prohibit drugmaker 340B contract pharmacy restrictions on grantee covered [...] …
A state Senate-endorsed bill that would have prohibited 340B contract pharmacy restrictions in Rhode Island failed to clear the legislature [...] …
French drugmaker Sanofi recently filed suit against federal agencies seeking details from contracts between 340B covered entities and outside pharmacies. [...] …
Federal Judge Presses Drug Industry on Preemption Arguments During Key Hearing on Louisiana 340B Law
A federal judge late last week pressed drug industry attorneys on their claims that Louisiana’s 340B contract pharmacy law oversteps [...] …
Organon, a spinoff of pharmaceutical giant Merck with a focus on women’s health, is now fully exempting West Virginia covered [...] …
Drugmaker Merck is fully exempting West Virginia covered entities from its 340B contract pharmacy restrictions, including all data submission requirements. [...] …
Canadian drugmaker Bausch & Lomb announced last week that, beginning July 1, it will no longer offer 340B discounted products [...] …
Irish drugmaker Alkermes will implement, on July 22, 340B contract pharmacy restrictions. The Dublin-based manufacturer is the 36th drugmaker to [...] …